<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00146887</url>
  </required_header>
  <id_info>
    <org_study_id>21-03.09.04-HMO-CTIL</org_study_id>
    <secondary_id>Non applicable</secondary_id>
    <nct_id>NCT00146887</nct_id>
  </id_info>
  <brief_title>Comparison of Coronary CT Angiography to Invasive Coronary Angiography</brief_title>
  <official_title>A Trial Comparing the Sensitivity and Specificity of Coronary Angiography With Coronary CT Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      The purpose of the trial is to investigate the accuracy of coronary CT compared to the&#xD;
      conventional &quot;gold standard&quot; cardiac catheterization.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      40 Patients who are scheduled to undergo coronary angiogram will be recruited at Mount Scopus&#xD;
      and Ein Kerem. Patients will be excluded if they have one or more of the following conditions&#xD;
&#xD;
        1. CABG or stent implantation in the past.&#xD;
&#xD;
        2. Atrial fibrillation&#xD;
&#xD;
        3. Contraindication for beta blockers&#xD;
&#xD;
             1. Obstructive pulmonary disease&#xD;
&#xD;
             2. Severe peripheral vascular disease&#xD;
&#xD;
             3. Sick sinus syndrome or AV block greater than 1st degree.&#xD;
&#xD;
             4. Systolic blood pressure below 100 mm Hg.&#xD;
&#xD;
        4. Renal disease or other conditions that might increase the risk of contrast nephropathy&#xD;
           (diabetes mellitus, SLE, paraproteinemia, malignancy, liver disease)&#xD;
&#xD;
        5. Allergy to contrast material.&#xD;
&#xD;
      Coronary CT angiography: Patient preparation and data acquisition Pre-procedure preparation:&#xD;
      Following informed consent, patients will be scheduled to undergo coronary CT angiography&#xD;
      within 7 days prior to coronary angiogram. Patients with heart rates above 75 BPM's will be&#xD;
      given 25 mg of metoprolol P.O. 60-90 minutes before the test. If the patient does not reach&#xD;
      heart rate below 75, administration of additional IV metoprolol may be considered by a&#xD;
      cardiologist.&#xD;
&#xD;
      Scanning protocol: Images will be obtained using collimation of 16x0.75 mm, slice thickness 1&#xD;
      mm reconstructed at increments of 0.5 mm, rotation time 0.42 seconds, kVp 140 and mAs 400.&#xD;
      Prior to scanning, 120-150cc of non-ionic contrast material will be injected to a peripheral&#xD;
      vein at a rate of 4-5mm/sec. Images will be obtained with ECG gating.&#xD;
&#xD;
      Post processing: The Cardiac CT Angiography software (Philips, Cleveland, USA) allows&#xD;
      extraction of the coronary tree from the heart and analysis of the arterial lumen. This&#xD;
      application operates on the volume rendered image of the heart. After isolation of the&#xD;
      coronary tree, the software enables the selection of an artery for quantitative analysis of&#xD;
      its lumen. The obtained information includes presentation of the artery in panoramic views,&#xD;
      visualization of the artery and adjacent vascular anatomy in Maximum Intensity Projection&#xD;
      (MIP) mode for anatomical enhancement, and cross sectional views, perpendicular to the artery&#xD;
      axis for free lumen/diameter analysis, thus providing a tool to estimate stenosis severity&#xD;
      and dimensions. Using color mapping, plaque composition is delineated to distinguish&#xD;
      calcified from soft plaque.&#xD;
&#xD;
      The Cardiac Review software (Philips, Cleveland, USA) provides detailed views of the&#xD;
      patient's cardiac cycle and, using Cine function, allows dynamic viewing of the heart. Using&#xD;
      the scanning protocol specified above, cardiac image raw data and an ECG signal are recorded&#xD;
      simultaneously. The images are then reconstructed retrospectively in phases. Phases are&#xD;
      defined according to the percentage of cardiac contraction, and a series of images is named&#xD;
      according to the phase during which they are acquired. The heart can be viewed in any desired&#xD;
      cut plane, using the Multi-Planar Formatting (MPR) application.&#xD;
&#xD;
      The Cardiac Review software provides 2 modes of viewing the heart images (Multi Views):&#xD;
&#xD;
        -  Equal phase mode (multi-position), which allows viewing of a number of different cuts of&#xD;
           the heart, all at the same cardiac phase&#xD;
&#xD;
        -  Equal position mode (multi-phase), which allows viewing of the same cuts of the heart in&#xD;
           different phases The Cardiac Axes Positioning feature provides an easy way to orient the&#xD;
           heart to common cardiac views, including short axis, vertical long axis and horizontal&#xD;
           axis.&#xD;
&#xD;
      The Cine feature allows viewing the heart in motion. MPR allows scrolling through various&#xD;
      portions of the heart while viewing in the cine mode. The sequence can be saved as an AVI&#xD;
      format movie.&#xD;
&#xD;
      Angiography: Within 7 days following coronary CT angiography patients will undergo cardiac&#xD;
      catheterization with at least the following views: anterior-posterior (AP), right anterior&#xD;
      oblique (RAO) cranial, RAO caudal, left anterior oblique (LAO) cranial, and LAO caudal.&#xD;
      Additional views (e.g. AP caudal and AP cranial) are at the operator's discretion.&#xD;
&#xD;
      During the hospitalization all patients will undergo echocardiography to assess wall motion&#xD;
      abnormalities.&#xD;
&#xD;
      Image interpretation The data will be analyzed in using the following strategies&#xD;
&#xD;
        1. Basic individual transverse sections&#xD;
&#xD;
        2. Maximal intensity projections with at least 3 of the following views that are compatible&#xD;
           with angiogram: RAO, LAO and spider&#xD;
&#xD;
        3. Multiplanar reformation.&#xD;
&#xD;
        4. Three dimensional (3D) displays.&#xD;
&#xD;
      The coronary tree will be divided into the following segments which correlate to conventional&#xD;
      angiogram segments Proximal RCA, 2-mid RCA, 3-distal RCA and PL, 4-PDA, 5-LM, 6-proximal LAD,&#xD;
      7-mid LAD, 8-distal LAD, 9-largest diagonal, 10, proximal CX, 11-Distal CX, 12-largest&#xD;
      marginal.&#xD;
&#xD;
      These segments will be evaluated by a consensus reading of a cardiologist and a radiologist&#xD;
      for the following parameters: existence of atherosclerosis, existence of calcification,&#xD;
      percent narrowing within the following ranges &lt;50%, 50%-70%, 70%-90%, tight. These scorings&#xD;
      will be used later for comparison with the angiogram results. The physicians interpreting the&#xD;
      CT results will be blinded to the results of the angiogram.&#xD;
&#xD;
      For analysis of myocardial function, an axial image series at the mid ventricular level&#xD;
      showing papillary muscles through the entire cardiac cycle will be performed to visually&#xD;
      identify the maximal systolic constriction phase and diastolic phase as the images showing&#xD;
      the largest and smallest left ventricular cavity area, respectively. The corresponding delay&#xD;
      in milliseconds from the R peak of the ECG will be used for image reconstruction. Then, a&#xD;
      short and a ling axis reconstructed views will be performed to be analyzed at diastole and&#xD;
      systole using Simson's disk method to calculate cardiac function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <completion_date type="Anticipated">August 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CT sensitivity and specificity</measure>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Atherosclerosis, Coronary</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>coronary catheterization</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        40 Patients who are scheduled to undergo coronary angiogram will be recruited at Mount&#xD;
        Scopus and Ein Kerem&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. CABG or stent implantation in the past.&#xD;
&#xD;
          2. Atrial fibrillation&#xD;
&#xD;
          3. Contraindication for beta blockers&#xD;
&#xD;
               1. Obstructive pulmonary disease&#xD;
&#xD;
               2. Severe peripheral vascular disease&#xD;
&#xD;
               3. Sick sinus syndrome or AV block greater than 1st degree.&#xD;
&#xD;
               4. Systolic blood pressure below 100 mm Hg.&#xD;
&#xD;
          4. Renal disease or other conditions that might increase the risk of contrast nephropathy&#xD;
             (diabetes mellitus, SLE, paraproteinemia, malignancy, liver disease)&#xD;
&#xD;
          5. Allergy to contrast material.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ronen durst, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ronen Durst, MD</last_name>
    <phone>972-2-6777111</phone>
    <email>durst@cc.huji.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronen Durst, MD</last_name>
      <phone>972-2-50-7874548</phone>
      <email>durst@cc.huji.ac.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2005</verification_date>
  <study_first_submitted>September 4, 2005</study_first_submitted>
  <study_first_submitted_qc>September 4, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2005</study_first_posted>
  <last_update_submitted>November 6, 2006</last_update_submitted>
  <last_update_submitted_qc>November 6, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2006</last_update_posted>
  <keyword>Coronary CT</keyword>
  <keyword>sensitivity</keyword>
  <keyword>specificity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

